Annual Cash & Cash Equivalents
$3.71 M
-$13.20 M-78.08%
30 June 2024
Summary:
MEI Pharma annual cash & cash equivalents is currently $3.71 million, with the most recent change of -$13.20 million (-78.08%) on 30 June 2024. During the last 3 years, it has fallen by -$4.84 million (-56.63%). MEIP annual cash & cash equivalents is now -89.58% below its all-time high of $35.57 million, reached on 30 June 2013.MEIP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$6.95 M
+$3.25 M+87.64%
30 September 2024
Summary:
MEI Pharma quarterly cash and cash equivalents is currently $6.95 million, with the most recent change of +$3.25 million (+87.64%) on 30 September 2024. Over the past year, it has increased by +$3.58 million (+106.17%). MEIP quarterly cash and cash equivalents is now -82.52% below its all-time high of $39.76 million, reached on 31 December 2013.MEIP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MEIP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.1% | +106.2% |
| 3 y3 years | -56.6% | -55.5% |
| 5 y5 years | -61.4% | +16.2% |
MEIP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.1% | at low | -58.9% | +193.6% |
| 5 y | 5 years | -78.1% | at low | -58.9% | +193.6% |
| alltime | all time | -89.6% | at low | -82.5% | +193.6% |
MEI Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.95 M(+87.6%) |
| June 2024 | $3.71 M(-78.1%) | $3.71 M(+56.5%) |
| Mar 2024 | - | $2.37 M(-54.2%) |
| Dec 2023 | - | $5.17 M(+53.4%) |
| Sept 2023 | - | $3.37 M(-80.1%) |
| June 2023 | $16.91 M(+7.4%) | $16.91 M(+91.9%) |
| Mar 2023 | - | $8.81 M(-19.3%) |
| Dec 2022 | - | $10.92 M(-25.5%) |
| Sept 2022 | - | $14.65 M(-6.9%) |
| June 2022 | $15.74 M(+84.2%) | $15.74 M(+41.6%) |
| Mar 2022 | - | $11.11 M(-11.5%) |
| Dec 2021 | - | $12.55 M(-19.7%) |
| Sept 2021 | - | $15.62 M(+82.9%) |
| June 2021 | $8.54 M(-30.7%) | $8.54 M(-12.3%) |
| Mar 2021 | - | $9.74 M(-1.3%) |
| Dec 2020 | - | $9.88 M(-9.8%) |
| Sept 2020 | - | $10.96 M(-11.2%) |
| June 2020 | $12.33 M(+28.6%) | $12.33 M(+65.8%) |
| Mar 2020 | - | $7.44 M(-13.9%) |
| Dec 2019 | - | $8.64 M(+44.4%) |
| Sept 2019 | - | $5.98 M(-37.6%) |
| June 2019 | $9.59 M(-27.9%) | $9.59 M(+29.1%) |
| Mar 2019 | - | $7.43 M(-15.1%) |
| Dec 2018 | - | $8.75 M(+43.0%) |
| Sept 2018 | - | $6.12 M(-54.0%) |
| June 2018 | $13.31 M(+57.4%) | $13.31 M(+114.7%) |
| Mar 2018 | - | $6.20 M(-15.5%) |
| Dec 2017 | - | $7.34 M(+5.5%) |
| Sept 2017 | - | $6.96 M(-17.7%) |
| June 2017 | $8.46 M(-22.0%) | $8.46 M(-27.4%) |
| Mar 2017 | - | $11.64 M(-22.6%) |
| Dec 2016 | - | $15.05 M(+9.1%) |
| Sept 2016 | - | $13.79 M(+27.2%) |
| June 2016 | $10.84 M(-42.1%) | $10.84 M(-24.2%) |
| Mar 2016 | - | $14.29 M(+4.5%) |
| Dec 2015 | - | $13.67 M(-23.5%) |
| Sept 2015 | - | $17.88 M(-4.5%) |
| June 2015 | $18.72 M(+35.9%) | $18.72 M(-8.5%) |
| Mar 2015 | - | $20.46 M(-13.5%) |
| Dec 2014 | - | $23.66 M(+38.8%) |
| Sept 2014 | - | $17.04 M(+23.7%) |
| June 2014 | $13.78 M | $13.78 M(-30.0%) |
| Mar 2014 | - | $19.67 M(-50.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | - | $39.76 M(+26.2%) |
| Sept 2013 | - | $31.50 M(-11.4%) |
| June 2013 | $35.57 M(+473.6%) | $35.57 M(+47.2%) |
| Mar 2013 | - | $24.17 M(-10.1%) |
| Dec 2012 | - | $26.88 M(+623.9%) |
| Sept 2012 | - | $3.71 M(-40.1%) |
| June 2012 | $6.20 M(+60.8%) | $6.20 M(+127.8%) |
| Mar 2012 | - | $2.72 M(-45.5%) |
| Dec 2011 | - | $4.99 M(+4.0%) |
| Sept 2011 | - | $4.80 M(+24.4%) |
| June 2011 | $3.86 M(-57.3%) | $3.86 M(-20.5%) |
| Mar 2011 | - | $4.85 M(-16.7%) |
| Dec 2010 | - | $5.83 M(-22.1%) |
| Sept 2010 | - | $7.48 M(-17.2%) |
| June 2010 | $9.03 M(-52.6%) | $9.03 M(-20.4%) |
| Mar 2010 | - | $11.34 M(-11.5%) |
| Dec 2009 | - | $12.81 M(-15.9%) |
| Sept 2009 | - | $15.23 M(-20.1%) |
| June 2009 | $19.07 M(-3.4%) | $19.07 M(-17.6%) |
| Mar 2009 | - | $23.15 M(-7.4%) |
| Dec 2008 | - | $24.99 M(-7.2%) |
| Sept 2008 | - | $26.94 M(+36.5%) |
| June 2008 | $19.74 M(+22.2%) | $19.74 M(-13.8%) |
| Mar 2008 | - | $22.90 M(-13.8%) |
| Dec 2007 | - | $26.57 M(-8.1%) |
| Sept 2007 | - | $28.93 M(+79.0%) |
| June 2007 | $16.16 M(+60.7%) | $16.16 M(-11.6%) |
| Mar 2007 | - | $18.27 M(-9.7%) |
| Dec 2006 | - | $20.23 M(-3.2%) |
| Sept 2006 | - | $20.89 M(+107.8%) |
| June 2006 | $10.05 M(+8.8%) | $10.05 M(-21.8%) |
| Mar 2006 | - | $12.86 M(-27.5%) |
| Dec 2005 | - | $17.73 M(+110.6%) |
| Sept 2005 | - | $8.42 M(-8.8%) |
| June 2005 | $9.24 M(-62.8%) | $9.24 M(-54.3%) |
| Mar 2005 | - | $20.23 M(-12.4%) |
| Dec 2004 | - | $23.11 M(-2.8%) |
| Sept 2004 | - | $23.78 M(-4.2%) |
| June 2004 | $24.82 M(+242.6%) | $24.82 M(-2.8%) |
| Mar 2004 | - | $25.55 M(-20.9%) |
| Dec 2003 | - | $32.30 M(+406.7%) |
| Sept 2003 | - | $6.38 M(-12.0%) |
| June 2003 | $7.24 M(-21.0%) | $7.24 M |
| June 2002 | $9.16 M | - |
FAQ
- What is MEI Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for MEI Pharma?
- What is MEI Pharma annual cash & cash equivalents year-on-year change?
- What is MEI Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for MEI Pharma?
- What is MEI Pharma quarterly cash and cash equivalents year-on-year change?
What is MEI Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of MEIP is $3.71 M
What is the all time high annual cash & cash equivalents for MEI Pharma?
MEI Pharma all-time high annual cash & cash equivalents is $35.57 M
What is MEI Pharma annual cash & cash equivalents year-on-year change?
Over the past year, MEIP annual cash & cash equivalents has changed by -$13.20 M (-78.08%)
What is MEI Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MEIP is $6.95 M
What is the all time high quarterly cash and cash equivalents for MEI Pharma?
MEI Pharma all-time high quarterly cash and cash equivalents is $39.76 M
What is MEI Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, MEIP quarterly cash and cash equivalents has changed by +$3.58 M (+106.17%)